MicroRNAs Change the Landscape of Cancer Resistance

作者: Jun Zhu , Wei Zhu , Wei Wu

DOI: 10.1007/978-1-4939-7435-1_6

关键词:

摘要: One of the major challenges in cancer treatment is development drug resistance. It represents a obstacle to curing with constrained efficacy both conventional chemotherapy and targeted therapies, even recent immune checkpoint blockade therapy. Deciphering mechanisms resistance critical further understanding multifactorial pathways involved, developing more specific treatments. To date, numerous studies have reported potential role microRNAs (miRNAs) various MicroRNAs are family small noncoding RNAs that regulate gene expression by sequence-specific targeting mRNAs causing translational repression or mRNA degradation. More than 1200 validated human miRNAs been identified genome. While one miRNA can hundreds targets, single target also be affected multiple miRNAs. Evidence suggests dysregulation may involved acquisition resistance, thereby modulating sensitivity cells treatment. Therefore, manipulation an attractive strategy for effective individualized therapies through reprograming resistant network cells.

参考文章(32)
Wei Wu, Jennifer A. Chan, Understanding the Role of Long Noncoding RNAs in the Cancer Genome Springer, New York, NY. pp. 199- 215 ,(2013) , 10.1007/978-1-4614-7645-0_10
Wei Wu, None, Modulation of MicroRNAs for Potential Cancer Therapeutics MicroRNA and Cancer. ,vol. 676, pp. 59- 70 ,(2011) , 10.1007/978-1-60761-863-8_5
Thomas Powles, Joseph Paul Eder, Gregg D. Fine, Fadi S. Braiteh, Yohann Loriot, Cristina Cruz, Joaquim Bellmunt, Howard A. Burris, Daniel P. Petrylak, Siew-leng Teng, Xiaodong Shen, Zachary Boyd, Priti S. Hegde, Daniel S. Chen, Nicholas J. Vogelzang, MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer Nature. ,vol. 515, pp. 558- 562 ,(2014) , 10.1038/NATURE13904
Philip J Stephens, Patrick S Tarpey, Helen Davies, Peter Van Loo, Chris Greenman, David C Wedge, Serena Nik-Zainal, Sancha Martin, Ignacio Varela, Graham R Bignell, Lucy R Yates, Elli Papaemmanuil, David Beare, Adam Butler, Angela Cheverton, John Gamble, Jonathan Hinton, Mingming Jia, Alagu Jayakumar, David Jones, Calli Latimer, King Wai Lau, Stuart McLaren, David J McBride, Andrew Menzies, Laura Mudie, Keiran Raine, Roland Rad, Michael Spencer Chapman, Jon Teague, Douglas Easton, Anita Langerød, Oslo Breast Cancer Consortium (OSBREAC) Karesen Rolf 34 35 Schlichting Ellen 34 Naume Bjorn 35 36 Sauer Torill 35 37 Ottestad Lars 36, Ming Ta Michael Lee, Chen-Yang Shen, Benita Tan Kiat Tee, Bernice Wong Huimin, Annegien Broeks, Ana Cristina Vargas, Gulisa Turashvili, John Martens, Aquila Fatima, Penelope Miron, Suet-Feung Chin, Gilles Thomas, Sandrine Boyault, Odette Mariani, Sunil R Lakhani, Marc van de Vijver, Laura van ‘t Veer, John Foekens, Christine Desmedt, Christos Sotiriou, Andrew Tutt, Carlos Caldas, Jorge S Reis-Filho, Samuel AJR Aparicio, Anne Vincent Salomon, Anne-Lise Børresen-Dale, Andrea L Richardson, Peter J Campbell, P Andrew Futreal, Michael R Stratton, None, The landscape of cancer genes and mutational processes in breast cancer Nature. ,vol. 486, pp. 400- 404 ,(2012) , 10.1038/NATURE11017
Natalia Komarova, Stochastic modeling of drug resistance in cancer. Journal of Theoretical Biology. ,vol. 239, pp. 351- 366 ,(2006) , 10.1016/J.JTBI.2005.08.003
R. C. Lee, An Extensive Class of Small RNAs in Caenorhabditis elegans Science. ,vol. 294, pp. 862- 864 ,(2001) , 10.1126/SCIENCE.1065329
Peter Duesberg, Daniele Mandrioli, Amanda McCormack, Joshua M. Nicholson, Is carcinogenesis a form of speciation Cell Cycle. ,vol. 10, pp. 2100- 2114 ,(2011) , 10.4161/CC.10.13.16352
Vivien Wang, Wei Wu, MicroRNA-Based Therapeutics for Cancer BioDrugs. ,vol. 23, pp. 15- 23 ,(2009) , 10.2165/00063030-200923010-00002
Christopher Greenman, Philip Stephens, Raffaella Smith, Gillian L. Dalgliesh, Christopher Hunter, Graham Bignell, Helen Davies, Jon Teague, Adam Butler, Claire Stevens, Sarah Edkins, Sarah O’Meara, Imre Vastrik, Esther E. Schmidt, Tim Avis, Syd Barthorpe, Gurpreet Bhamra, Gemma Buck, Bhudipa Choudhury, Jody Clements, Jennifer Cole, Ed Dicks, Simon Forbes, Kris Gray, Kelly Halliday, Rachel Harrison, Katy Hills, Jon Hinton, Andy Jenkinson, David Jones, Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, Dave Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P. Cahill, David N. Louis, Peter Goldstraw, Andrew G. Nicholson, Francis Brasseur, Leendert Looijenga, Barbara L. Weber, Yoke-Eng Chiew, Anna deFazio, Mel F. Greaves, Anthony R. Green, Peter Campbell, Ewan Birney, Douglas F. Easton, Georgia Chenevix-Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P. Andrew Futreal, Michael R. Stratton, Patterns of somatic mutation in human cancer genomes Nature. ,vol. 446, pp. 153- 158 ,(2007) , 10.1038/NATURE05610